Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)

Publication | Open Access

DOI Full Paper Access

120

Citations

References

2012

Year

Volker Heinemann, Ursula Vehling‐Kaiser, Dirk Waldschmidt, E. Kettner, Angela Märten, Cornelia Winkelmann, Stefan Klein, G. Kojouharoff, Thomas Gauler, Ludwig Fischer von Weikersthal,

Gut

Abstract

References